Skip to main content

The association of female reproductive factors with risk of metabolic syndrome in women from NHANES 1999–2018

Abstract

Background

Female reproductive factors such as age at first birth (AFB), age at last birth (ALB), number of pregnancies and live births play an essential role in women’s health. However, few epidemiological studies have evaluated the association between female reproductive factors and metabolic syndrome (MetS). We therefore conducted a cross-sectional study to investigate the association between MetS risk and female reproductive factors.

Methods

We investigated the relationship between AFB, ALB, number of pregnancies and live births and the incidence of MetS using publicly available data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. Weighted multivariable logistic regression analysis, restricted cubic spline (RCS) model, and subgroup analysis were used to evaluate the association between AFB and ALB and the risk of MetS in women. In addition, the relationship between the number of pregnancies, live births and MetS risk was also explored.

Results

A total of 15,404 women were included in the study, and 5,983 (38.8%) had MetS. RCS models showed an N-shaped relationship between AFB and MetS risk, whereas ALB, number of pregnancies, and live births were linearly associated with MetS. Weighted multivariable logistic regression analysis showed that the number of live births was associated with MetS risk, with ORs of 1.18 (95% CI: 1.04, 1.35) for women with ≥ 5 deliveries compared to women with ≤ 2 births.

Conclusions

AFB was associated with the risk of MetS in an N-shaped curve in women. In addition, women with high live births have a higher incidence of MetS.

Peer Review reports

Introduction

Metabolic syndrome (MetS) is a group of clinical syndromes, including abdominal obesity, hyperglycemia, dyslipidemia, and hypertension [1]. The prevalence of MetS in adults is about 37.3% [2], which has become a global disease that seriously affects human health. Studies have found that the prevalence of MetS in China is 25%, with a prevalence of 19.2% in men and 27.0% in women [3]. The risk of cardiovascular disease in patients with MetS is two times higher than that in non-MetS patients, and the risk of death is 1.5 times higher than that in non-MetS patients [4]. Studies have shown that the core pathophysiological basis of MetS is insulin resistance, and many factors, including genes, metabolism, and environmental factors, are related to the occurrence of MetS [5]. Female reproductive factors such as age at first pregnancy (AFB), age at last birth (ALB), number of pregnancies, and live births play an essential role in female health. Previous studies have shown that early AFB is associated with metabolic diseases such as Non-alcoholic fatty liver disease, obesity, and diabetes [6,7,8]. Epidemiological studies on the relationship between AFB, ALB, number of pregnancies and live births, and MetS are limited, and the results are inconsistent. Lee et al. found that postmenopausal women with more births had a higher risk of developing MetS [9]. However, Moosazadeh et al.’s study showed no relationship between number of pregnancies and MetS [10]. Some studies have shown an increased risk of MetS in postmenopausal women who give birth to their first child early [11, 12], while others have found no association between early AFB and MetS risk [10]. There are few studies on the relationship between female reproductive factors and MetS, and the few available studies have conflicting results; therefore, further validation in a larger population is needed. Thus, the present study aims to investigate the association between female reproductive factors and the risk of MetS using the National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2018 in the United States (U.S.).

Material and methods

Study population

The NHANES database is a health and nutrition survey data set for the American population and is a project of the Centers for Disease Control and Prevention [13]. The program aims to provide health and dietary guidance to U.S. residents and improve public health policy. More details about NHANES can be accessed at the website: https://www.cdc.gov/nchs/nhanes/. The NCHS Ethics Review Board approved the protocol and obtained written informed consent from all participants. The subjects of this study were women participants in the NHANES database from 1999 to 2018. Exclusion criteria were: (1) lack of data on AFB, ALB, number of pregnancies, and live births; (2) missing MetS data. A total of 49,209 women participants were included, with missing data on female reproductive factors (n = 33,283) and MetS (n = 522) excluded, and 15,404 women were ultimately included in the study.

Reproductive factors

The ages of first and last pregnancies were determined by answering the following questions: “How old were you at the time of your first live birth?” and “How old were you at the time of your last live birth?”. The number of pregnancies was assessed by calculating the number of all pregnancies in the participants, including current pregnancies, live births, miscarriages, stillbirths, tubal pregnancies, or abortions). In contrast, the number of live births was assessed by calculating the total number of pregnancies that resulted in a live birth rather than the number of babies born alive. To evaluate contraceptive use, participants were asked, “Have you ever taken birth control pills for any reason?”. And for using female hormones, participants were asked, “Have you ever used female hormones such as estrogen and progesterone? Please include any form of female hormones, such as pills, creams, patches, and injections, but do not include birth control or use for infertility”. In addition, reproductive factors, including menopausal status, age at menarche, age at menopause, history of hysterectomy, and history of bilateral oophorectomy, were also obtained from the reproductive health questionnaire. Fertility life is the difference between the age of menopause and the age of menarche. We defined pregnancy loss as the difference between the total number of self-reported pregnancies and live births [14]. Further information about this questionnaire data can be found at https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/RHQ_H.htm#RHQ160.

MetS ascertainment

MetS can be diagnosed when three of the following five conditions are present, according to criteria proposed by the American Endocrine Society and the American Society of Clinical Endocrinology [15]: (1) waist circumference (WC) elevation (≥ 88 cm in women and ≥ 102 cm in men), (2) elevated triglycerides (TG, ≥ 150 mg/dL) or drug-treated TG, (3) low high-density lipoprotein-cholesterol (HDL-C, < 40 mg/dL for men and < 50 mg/dL for women) or use of drugs for low HDL-C, (4) elevated blood pressure (systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥ 85 mmHg or both) or antihypertensive drug use, (5) elevated fast glucose ≥ 100 mg/dL or drug therapy for hyperglycemia.

Covariates

The study incorporated a range of covariates for analysis, including demographic variables (age, race, family income-to-poverty ratio (PIR), education level, and marital status), questionnaire data (diabetes mellitus (DM), smoker, coronary heart disease (CHD), alcohol user, angina pectoris, heart attack, congestive heart failure (CHF), hypertension and stroke), dietary data (mean energy intake), and laboratory data (hemoglobin (Hb), fast blood glucose (FBG), serum creatinine (Scr), glycosylated hemoglobin (HbA1c), uric acid (UA), total cholesterol (TC), triglycerides (TG), blood urea nitrogen (BUN), HDL-C, estimated glomerular filtration rate (eGFR)), Examination data (body mass index (BMI), WC, and blood pressure). Individuals who smoked less than 100 cigarettes during their lifetime, those who smoked more than 100 cigarettes in their lifetime but were not currently smokers, and those who smoked more than 100 cigarettes in their lifetime or who now smoked every day or several days were defined as nonsmokers, former and current smokers, respectively. Detailed covariates information is publicly obtained from the NHANES database (https://www.cdc.gov/nchs/nhanes/).

Statistical analysis

All NHANES estimations were sample weights computed. According to data distribution characteristics, continuous variables use mean ± standard deviation or interquartile range to describe the trend of data concentration, and categorical variables use frequency to describe. Weighted T-tests or Mann-Whitney U test were used to compare between-group differences for continuous variables. Weighted multivariable logistic regression analysis was used to explore the association between AFB, ALB, number of pregnancies, live births and MetS. Model 1 adjusted for age and race/ethnicity, and Model 2 adjusted for age, race/ethnicity, education level, marriage status, family PIR, hypertension, smoking, and alcohol use. Model 3 was based on Model 2 with adjustments for CHD, CHF, heart attack, angina pectoris and stroke, age at menopause, BMI, WC, SBP, DBP, mean energy intake, Hb, FBG, HbA1c, menopausal status, age at menarche, oral contraceptives, use of female hormones, previous hysterectomy, bilateral ovariectomy, BUN, UA, Scr, eGFR, TC, TG, HDL-C, number of live births and pregnancies, pregnancy loss and fertile lifespan. Based on Model 3, subgroup analyses were performed to examine whether the effects of AFB and ALB on MetS could be changed by age, race, menopausal status, hysterectomy, female hormone use, age at menarche, or reproductive age. In addition, restrictive cubic splines (RCS) were used to analyze the association between AFB, ALB, number of live births, pregnancies and MetS. Statistical analysis was performed using Rstudio 3.6.4 and SPSS 22.0. P-value < 0.05 was considered statistically significant.

Results

Baseline characteristics

The overall prevalence of MetS in the included study population was 38.8% (5983/15404). The average age of MetS patients was significantly higher than that of non-MetS population (P < 0.001).

The mean values of WC, SBP, DBP, FBG, TG, and HDL-C in patients with MetS were 107.19 ± 0.27 cm, 129.50 ± 0.40 mmHg, 71.83 ± 0.30 mmHg, 119.84 ± 0.78 mg/dL, 183.38 ± 2.30 mg/dL and 46.25 ± 0.22 mg/dL, respectively. There were significant differences in AFB, number of live births, and number of pregnancies between non-MetS and MetS participants (P < 0.001). The baseline characteristics of the study population are shown in Table 1.

Table 1 Demographic characteristics of the study participants

Association between AFB, ALB, number of pregnancies, live births, and MetS

We used the RCS fitted model to plot the change in risk of MetS with increasing AFB, ALB, number of pregnancies and live births. After adjusting for covariates, the association between AFB and MetS showed a nonlinear relationship, peaking at about 19 years of age and the risk of MetS decreasing as the AFB increased with an N-shaped curve (P for nonlinearity = 0.036, Fig. 1A). However, the association between ALB, number of pregnancies, and live births and MetS was a linear relationship, and the risk of MetS increased with increasing ALB, number of pregnancies and live births (ALB, P for nonlinearity = 0.186, Fig. 1B; the number of pregnancies, P for nonlinearity = 0.803, Fig. 2A; the number of live births, P for nonlinearity = 0.251, Fig. 2B). The relationship between AFB, ALB, and the risk of MetS is presented in Table 2. In studying the association between AFB and MetS, patients were divided into eight groups based on age: < 18, 18–20, 21–23, 24–26, 27–29, 30–32, 33–35, and ≥ 36 years. Weighted multivariable logistic regression analysis showed that after adjusting for race and age, participants with AFB of 21–23, 24–26, 27–29, 30–32, 33–35, and ≥ 36 had a significantly lower risk of MetS compared with those with AFB < 18, with ORs of 0.81 (95% CI: 0.72, 0.90), 0.71 (95% CI: 0.63, 0.80), 0.67 (95% CI: 0.58, 0.77), 0.58 (95% CI: 0.47, 0.70), 0.59 (95% CI: 0.47, 0.70) and 0.50 (95% CI: 0.35, 0.71), respectively (P for trend < 0.001). After further adjustment for covariates in models 2 and 3, AFB was not associated with an increased risk of MetS. In addition, in studying the association between ALB and MetS, participants were grouped into ≤ 24, 25–29, 30–34, 35–39, and ≥ 40 years, and ALB was not associated with the risk of MetS in model 2 and 3 (Table 2). Second, we divided the participants into four groups according to the number of pregnancies and live births: ≤ 2, 3, 4, and ≥ 5. The risk of MetS was significantly higher in participants with more than four pregnancies in model 1, but statistical significance was not maintained after adjustment for covariates in models 2 and 3. Notably, the greater the number of live births, the higher the risk of MetS in model 1. After further adjustment for confounding factors, the risk of having MetS was significantly higher in the participants whose number of live births was ≥ 5 in models 2 and 3 (Table 3).

Fig. 1
figure 1

Restricted cubic spline plots of associations between A AFB, B ALB and prevalence of MetS. Abbreviation: AFB, age at first birth; ALB, age at last birth; MetS, metabolic syndrome

Fig. 2
figure 2

Restricted cubic spline plots of associations between A number of pregnancies and B live births and prevalence of MetS. Abbreviation: MetS, metabolic syndrome

Table 2 Associations of AFB, and ALB with the risk of MetS
Table 3 Associations of number of pregnancies, and number of live births with the risk of MetS

Subgroup analyses

Table 4 shows a stronger association between AFB and MetS among participants younger than 45 years, Mexican Americans and other ethnicities, and women who had hysterectomy. Additionally, there was a significant interaction for most subgroups (P for interaction < 0.05). And a stronger association between ALB and MetS was found in other Hispanic individuals, older at menarche, non-hysterectomized, and with a fertile lifespan > 35 years, respectively (Table 5). Notably, the association differed among the subgroups for age, race, menopausal status, hysterectomy, age at menarche, female hormone use and fertile lifespan (P for interaction < 0.05).

Table 4 Subgroups analysis for the associations of AFB with the risk of MetS
Table 5 Subgroups analysis for the associations of ALB with the risk of MetS

Discussion

This study is a cross-sectional study of female participants with information on female reproductive factors and MetS in the NHANES database (1999–2018). We observed N-shaped relationships between MetS risk and AFB. The prevalence of MetS was significantly higher in participants with ≥ 5 deliveries compared to those with ≤ 2 births (OR = 1.18, 95% CI: 1.04, 1.35). Further analysis using RCS models showed a linear relationship between increased ALB, increased number of pregnancies and live births and risk of MetS.

The incidence of MetS in women in this study was similar to that in Zhou et al. [16]. Some evidence also suggests that younger AFB is associated with an increased risk of metabolic disease [17,18,19]. Sim et al. showed that early AFB was associated with an elevated risk of MetS in postmenopausal women [12]. A possible mechanism is that younger AFB is related to various components of metabolic disorders, such as increased BMI [8], elevated blood pressure and triglyceride [12]. In addition, women with a first child at a younger age are likely to be less educated and have a lower economic level, which may be accompanied by poorer nutritional quality, thereby increasing the incidence of MetS [20]. The results of a large cohort study in Iran showed no association between AFB and the development of MetS [10]. Different findings may be related to different populations included in the study. Therefore, the correlation between AFB and MetS risk needs to be confirmed by further research. Few studies have examined the association between ALB and the prevalence of MetS. Our findings suggest a linear relationship between ALB and MetS risk. However, Shin et al. showed that a younger age at the last birth was associated with an increased risk of MetS in postmenopausal women [21]. Previous studies have shown that the risk of DM was significantly reduced at the later ALB [22]. The relationship between ALB and MetS and their components needs to be further studied. Moosazadeh et al. showed no association between number of pregnancies and MetS, but more pregnancies were a risk factor for increased WC in women [10]. Our results suggest that women with more than 5 live births were 1.18 times more likely to develop MetS than those with 2 live births, whereas there was no similar association for the number of pregnancies. Complete labor has a more significant impact on female hormones than pregnancy. Wu et al. showed that parity was associated with a 52% higher risk of MetS in women who gave birth four or more times [23]. Several studies in China also support a positive correlation between multiple births and MetS [23, 24]. However, shi et al. showed that multiparity was unrelated to MetS in normal-weight postmenopausal women [25]. The possible mechanisms are as follows. (i) Pregnancy-related weight gain can lead to subsequent obesity [26]. Pregnancy may also induce unhealthy behaviors, such as less activity and excessive caloric intake, which may also contribute to obesity. The duration of obesity is a significant risk factor for diabetes [27]. (ii) Pregnancy is characterized by increased adipose tissue and lipolysis, insulin resistance, and inflammation [28, 29], which may persist after delivery. (iii) Moreover, pregnancy-related complications such as gestational diabetes mellitus and gestational hypertension are associated with type 2 diabetes (T2DM) and cardiovascular disease in later life [30, 31]. Multiple births are also considered a risk factor for T2DM in later life [7, 32].

Our study has some strengths. First, this study explored the relationship between four important female reproductive factors and MetS, providing evidence for reducing the incidence of MetS in women. Secondly, this study has a large sample size and many covariates to ensure the reliability of the results. However, this study also has some limitations. We did not analyze the relationship between female reproductive factors and the components of MetS. Data on midwifery characteristics, pre- and post-pregnancy BMI, and breastfeeding history per pregnancy were not available, and these data may impact MetS risk in the future [33]. Then, as this study is a cross-sectional study, the exact mechanism between reproductive factors and MetS is unclear, and more trials are needed to discover the association of female reproductive factors with the incidence of MetS in the future. Finally, our study population was derived from the NHANES database, so the findings may not be appropriate for other races worldwide.

Conclusion

Our results demonstrated that AFB displayed an N-curve association with MetS, while ALB, number of pregnancies, and live births were positively associated with MetS based on the large cross-sectional study. In order to reduce the risk of MetS in women, further research is needed to focus on the potential mechanisms of the relationship between female reproductive factors and MetS.

Availability of data and materials

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.

    Article  Google Scholar 

  2. Zhu L, Rahman A, Yeh MC, Ma GX. Racial/ethnic disparities of cancer, metabolic syndrome, and lifestyle behaviors in people under 50: a cross-sectional study of data from the National Health and Nutrition Examination Survey. Epidemiologia (Basel, Switzerland). 2022;3(4):493–501.

    PubMed  Google Scholar 

  3. Li R, Li W, Lun Z, Zhang H, Sun Z, Kanu JS, Qiu S, Cheng Y, Liu Y. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16:296.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

    Article  PubMed  Google Scholar 

  5. Fathi Dizaji B. The investigations of genetic determinants of the metabolic syndrome. Diabetes Metab Syndr. 2018;12(5):783–9.

    Article  PubMed  Google Scholar 

  6. Yang HH, Chen GC, Zhou MG, Xie LF, Jin YY, Chen HT, et al. Association of age at first birth and risk of non-alcoholic fatty liver disease in women: evidence from the NHANES. Hepatol Int. 2023;17(2):303–12.

    Article  PubMed  Google Scholar 

  7. Fowler-Brown AG, de Boer IH, Catov JM, Carnethon MR, Kamineni A, Kuller LH, Siscovick DS, Mukamal KJ. Parity and the association with diabetes in older women. Diabetes Care. 2010;33(8):1778–82.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Patchen L, Leoutsakos JM, Astone NM. Early parturition: is young maternal age at first birth associated with obesity? J Pediatr Adolesc Gynecol. 2017;30(5):553–9.

    Article  PubMed  Google Scholar 

  9. Lee Y, Lee HN, Kim SJ, Koo J, Lee KE, Shin JE. Higher parity and risk of metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Examination Survey 2010–2012. J Obstet Gynaecol Res. 2018;44(11):2045–52.

    Article  PubMed  Google Scholar 

  10. Moosazadeh M, Takezaki T, Saeedi M, Kheradmand M. Association between gravidity and risk of metabolic syndrome: results of Tabari cohort study. Diabetes Metab Syndr. 2020;14(5):843–7.

    Article  PubMed  Google Scholar 

  11. Cho GJ, Park HT, Shin JH, Kim T, Hur JY, Kim YT, Lee KW, Kim SH. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005. Menopause (New York, NY). 2009;16(5):998–1003.

    Article  Google Scholar 

  12. Sim JH, Chung D, Lim JS, Lee MY, Chung CH, Shin JY, Huh JH. Maternal age at first delivery is associated with the risk of metabolic syndrome in postmenopausal women: from 2008–2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2015;10(5):e0127860.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr (Bethesda, Md). 2016;7(1):121–34.

    Article  Google Scholar 

  14. Gonzalez-Martin R, Grau-Perez M, Sebastian-Leon P, Diaz-Gimeno P, Vidal C, Tellez-Plaza M, Dominguez F. Association of blood cadmium and lead levels with self-reported reproductive lifespan and pregnancy loss: the national health and nutrition examination survey 1999–2018. Environ Res. 2023;233:116514.

    Article  CAS  PubMed  Google Scholar 

  15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

    Article  CAS  PubMed  Google Scholar 

  16. Zhou J, Meng X, Deng L, Liu N. Non-linear associations between metabolic syndrome and four typical heavy metals: data from NHANES 2011–2018. Chemosphere. 2022;291(Pt 2):132953.

    Article  CAS  PubMed  Google Scholar 

  17. Rosendaal NTA, Pirkle CM. Age at first birth and risk of later-life cardiovascular disease: a systematic review of the literature, its limitation, and recommendations for future research. BMC Public Health. 2017;17(1):627.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Parikh NI, Jeppson RP, Berger JS, Eaton CB, Kroenke CH, LeBlanc ES, Lewis CE, Loucks EB, Parker DR, Rillamas-Sun E, et al. Reproductive risk factors and coronary heart disease in the women’s health initiative observational study. Circulation. 2016;133(22):2149–58.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kim JH, Jung Y, Kim SY, Bae HY. Impact of age at first childbirth on glucose tolerance status in postmenopausal women: the 2008–2011 Korean National Health and Nutrition Examination Survey. Diabetes Care. 2014;37(3):671–7.

    Article  CAS  PubMed  Google Scholar 

  20. Marcotte-Chénard A, Deshayes TA, Ghachem A, Brochu M. Prevalence of the metabolic syndrome between 1999 and 2014 in the United States adult population and the impact of the 2007–2008 recession: an NHANES study. Appl Physiol Nutr Metab. 2019;44(8):861–8.

    Article  PubMed  Google Scholar 

  21. Shin JE, Han KD, Shin JC, Lee Y, Kim SJ. Association between maternal age at childbirth and metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Examination Survey 2010 to 2012. Menopause (New York, NY). 2017;24(2):196–202.

    Article  Google Scholar 

  22. Gu YW, Zhang S, Wang JH, Yang HL, Zhang SQ, Yao YD, Wu YY, Xie L, Li ZY, Cao JY. Number of births and risk of diabetes in China’s older women. Front Med. 2022;9:798787.

    Article  Google Scholar 

  23. Wu J, Xu G, Shen L, Zhang Y, Song L, Yang S, Yang H, Yuan J, Liang Y, Wang Y, et al. Parity and risk of metabolic syndrome among Chinese women. J Womens Health (2002). 2015;24(7):602–7.

    Article  Google Scholar 

  24. Yao Y, Liu HM, Wang XW, Feng X, Gao LJ, Li D, Zhou Y. Effect of body mass index on the associations between parity and metabolic syndrome and its components among northern Chinese women. Biomed Environ Sci. 2020;33(1):11–8.

    CAS  PubMed  Google Scholar 

  25. Shi M, Zhou X, Zheng C, Pan Y. The association between parity and metabolic syndrome and its components in normal-weight postmenopausal women in China. BMC Endocr Disord. 2021;21(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, Ramey S, Wang C, Hobel C, Raju T, et al. Postpartum weight retention risk factors and relationship to obesity at 1 year. Obstet Gynecol. 2015;125(1):144–52.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Everhart JE, Pettitt DJ, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes. 1992;41(2):235–40.

    Article  CAS  PubMed  Google Scholar 

  28. Vryonidou A, Paschou SA, Muscogiuri G, Orio F, Goulis DG. Mechanisms in endocrinology: metabolic syndrome through the female life cycle. Eur J Endocrinol. 2015;173(5):R153-163.

    Article  CAS  PubMed  Google Scholar 

  29. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine. 2002;19(1):43–55.

    Article  CAS  PubMed  Google Scholar 

  30. Durnwald C. Gestational diabetes: linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin Perinatol. 2015;39(4):254–8.

    Article  PubMed  Google Scholar 

  31. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart (British Cardiac Society). 2019;105(16):1273–8.

    PubMed  Google Scholar 

  32. Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. Parity and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2006;29(11):2349–54.

    Article  PubMed  Google Scholar 

  33. Tørris C, Bjørnnes AK. Duration of lactation and maternal risk of metabolic syndrome: a systematic review and meta-analysis. Nutrients. 2020;12(9):2718.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Thanks to all the volunteers who took part in the NHANES.

Funding

This work was supported by the Shanghai Jinshan District Health Commission Project Fund (grant number: JSKJ-KTMS-2019-21, grant number: JSKJ-KTMS-2020-09) and the Shanghai Jinshan District Medical and Health Science and Technology Innovation Fund Project (grant number: 2020-3-30).

Author information

Authors and Affiliations

Authors

Contributions

Ronghua Zuo, and Yuefei Wang contributed to the hypothesis development and the drafting of the manuscript; Yiting Ge, Jingbo Xu, Lin He and Tao Liu contributed to the data acquisition; Shasha Wang, Bing Wang, and Lifang Sun were responsible for the data analysis. Zhijian Zhu, Ronghua Zuo and Yuefei Wang contributed to the data interpretation and revision of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yuefei Wang.

Ethics declarations

Ethics approval and consent to participate

The National Center for Health Statistics Ethics Review Board approved the protocol and obtained written informed consent from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuo, R., Ge, Y., Xu, J. et al. The association of female reproductive factors with risk of metabolic syndrome in women from NHANES 1999–2018. BMC Public Health 23, 2306 (2023). https://doi.org/10.1186/s12889-023-17207-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-023-17207-0

Keywords